MedPath

Determinants of succesful discontinuation of antipsychotics used for behavioural symptoms in people with intellectual disability

Completed
Conditions
cognitions
neurological withdrawal symptoms
extrapyramidal symptoms
off-label use
antipsychotics
long-term use
behavioural symptoms
challenging behaviours
problem behaviours, intellectual disability
staff-related factors
Registration Number
NL-OMON21589
Lead Sponsor
niversity Medical Centre Groningen/department psychiatry
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
200
Inclusion Criteria

•Any sex or ethnicity

Exclusion Criteria

A potential subject who meets any of the following criteria will be excluded from participation in this study:

•A history of schizophrenia, a bipolar disorder, or affective psychosis according to DSM IV or ICD-10 criteria

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Achievement of complete discontinuation at the time point of<br>16 weeks (two weeks after the study discontinuation<br>schedule)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath